Prevention of Glucocorticoid‐Induced Apoptosis in Osteocytes and Osteoblasts by Calbindin‐D28k

This study show for the first time that calbindin‐D28k can prevent glucocorticoid‐induced bone cell death. The anti‐apoptotic effect of calbindin‐D28k involves inhibition of glucocorticoid induced caspase 3 activation as well as ERK activation.

[1]  S. Christakos,et al.  Expression of calbindin-D(28k) in a pancreatic islet beta-cell line protects against cytokine-induced apoptosis and necrosis. , 2001, Endocrinology.

[2]  S. Haldar,et al.  Identification of a novel Bcl‐xL phosphorylation site regulating the sensitivity of taxol‐ or 2‐methoxyestradiol‐induced apoptosis , 2003, FEBS letters.

[3]  John Calvin Reed,et al.  Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.

[4]  G. Salvesen,et al.  Target Protease Specificity of the Viral Serpin CrmA , 1997, The Journal of Biological Chemistry.

[5]  A. Tumber,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Multiple Extracellular Signals Promote Osteoblast Survival and Apoptosis* , 2022 .

[6]  S. Manolagas,et al.  Calbindin-D28k Is Expressed in Osteoblastic Cells and Suppresses Their Apoptosis by Inhibiting Caspase-3 Activity* , 2000, The Journal of Biological Chemistry.

[7]  E. Alnemri,et al.  Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. , 1995, Cancer research.

[8]  M. Mattson,et al.  Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. Katzenellenbogen,et al.  Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors Dissociation from Transcriptional Activity , 2001, Cell.

[10]  Jongdae Lee,et al.  IAP Suppression of Apoptosis Involves Distinct Mechanisms: the TAK1/JNK1 Signaling Cascade and Caspase Inhibition , 2002, Molecular and Cellular Biology.

[11]  M. Scheid,et al.  Regulation of Bad Phosphorylation and Association with Bcl-xL by the MAPK/Erk Kinase* , 1999, The Journal of Biological Chemistry.

[12]  S. Ikuyama,et al.  Glucocorticoid-induced osteoporosis: pathogenesis and management , 2000, Journal of Bone and Mineral Metabolism.

[13]  M. Almeida,et al.  Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. , 2003, The Journal of clinical investigation.

[14]  P. Roberson,et al.  Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. , 1999, The Journal of clinical investigation.

[15]  R. Landes,et al.  Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. , 2002, The Journal of clinical investigation.

[16]  R. Wasserman,et al.  Intestinal calcium-binding protein and calcium absorption in cortisol-treated chicks: effects of vitamin D3 and 1,25-dihydroxyvitamin D3. , 1979, Endocrinology.

[17]  J. Mankovich,et al.  Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. , 1995, Science.

[18]  S. Linse,et al.  myo-Inositol Monophosphatase Is an Activated Target of Calbindin D28k* , 2002, The Journal of Biological Chemistry.

[19]  Young Chul Park,et al.  Structural Basis of Caspase Inhibition by XIAP Differential Roles of the Linker versus the BIR Domain , 2001, Cell.

[20]  B. Komm,et al.  Stable expression of the calbindin-D28K complementary DNA interferes with the apoptotic pathway in lymphocytes. , 1992, Molecular endocrinology.

[21]  H. Cushing.  The Basophil Adenomas of the Pituitary Body and Their Clinical Manifestations (Pituitary Basophilism) , 1964 .

[22]  W. May,et al.  Phosphorylation of Bcl2 and regulation of apoptosis , 2001, Leukemia.

[23]  L. Raisz,et al.  Glucocorticoid-induced osteoporosis. , 1994, Rheumatic diseases clinics of North America.

[24]  S. Carr,et al.  Mapping phosphorylation sites in proteins by mass spectrometry. , 2002, Methods in enzymology.

[25]  E. Canalis.  Mechanisms of glucocorticoid action in bone , 2005, Annals of the New York Academy of Sciences.

[26]  M. Mattson,et al.  Evidence for calcium-reducing and excitoprotective roles for the calcium-binding protein calbindin-1328k in cultured hippocampal neurons , 1991, Neuron.

[27]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[28]  C. Heizmann,et al.  Calbindin‐D28k , 2002 .

[29]  R. Weinstein,et al.  Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. , 2000, The Journal of clinical endocrinology and metabolism.

[30]  S. Christakos,et al.  Vitamin D-dependent calcium binding proteins: chemistry, distribution, functional considerations, and molecular biology. , 1989, Endocrine reviews.

[31]  A. Parfitt,et al.  Osteoblast Programmed Cell Death (Apoptosis): Modulation by Growth Factors and Cytokines , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  I. Torres-Aleman,et al.  Insulin‐like growth factor I is an afferent trophic signal that modulates calbindin‐28kD in adult Purkinje cells , 1995, Journal of neuroscience research.

[33]  S. Korsmeyer.  Regulators of cell death. , 1995, Trends in genetics : TIG.

[34]  L. Bonewald,et al.  Establishment of an Osteocyte‐like Cell Line, MLO‐Y4 , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  S. Christakos,et al.  Rat calbindin D28K: purification, quantitation, immunocytochemical localization, and comparative aspects. , 1987, Methods in enzymology.

[36]  J C Reed,et al.  A Single BIR Domain of XIAP Sufficient for Inhibiting Caspases* , 1998, The Journal of Biological Chemistry.

[37]  Dean P. Jones,et al.  Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.

[38]  D. Green.  Apoptotic Pathways The Roads to Ruin , 1998, Cell.

[39]  M. Grütter,et al.  Structure of Recombinant Human CPP32 in Complex with the Tetrapeptide Acetyl-Asp-Val-Ala-Asp Fluoromethyl Ketone* , 1997, The Journal of Biological Chemistry.

[40]  J. Kukkonen,et al.  NAIP interacts with hippocalcin and protects neurons against calcium‐induced cell death through caspase‐3‐dependent and ‐independent pathways , 2000, The EMBO journal.

[41]  J C Reed,et al.  IAP family proteins--suppressors of apoptosis. , 1999, Genes & development.

[42]  I. Reid.  Glucocorticoid osteoporosis--mechanisms and management. , 1997, European journal of endocrinology.

[43]  R. Nissenson,et al.  Apoptosis mediated by activation of the G protein-coupled receptor for parathyroid hormone (PTH)/PTH-related protein (PTHrP). , 2000, Molecular endocrinology.

[44]  William D. Richardson,et al.  A short amino acid sequence able to specify nuclear location , 1984, Cell.

[45]  A. Parfitt,et al.  Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. , 1998, The Journal of clinical investigation.

[46]  S. Orrenius,et al.  CPP32/Apopain Is a Key Interleukin 1 Converting Enzyme-like Protease Involved in Fas-mediated Apoptosis (*) , 1996, The Journal of Biological Chemistry.

[47]  Thomas P Conrads,et al.  The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. , 2002, Biochemical and biophysical research communications.

[48]  S. Srinivasula,et al.  Structural Basis of Caspase-7 Inhibition by XIAP , 2001, Cell.

[49]  J. Cidlowski,et al.  Delineation of the signaling pathways involved in glucocorticoid-induced and spontaneous apoptosis of rat thymocytes. , 2000, Endocrinology.

[50]  D. Durant,et al.  Glucocorticoid suppression of IGF I transcription in osteoblasts. , 2001, Molecular endocrinology.

[51]  T. Chittenden,et al.  Growth Factors Inactivate the Cell Death Promoter BAD by Phosphorylation of Its BH3 Domain on Ser155 * , 2000, The Journal of Biological Chemistry.

[52]  S. Manolagas,et al.  Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. , 2000, Endocrine reviews.

[53]  P. Roberson,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Activation of the Janus Kinase/STAT (Signal Transducer and Activator of Transcription) Signal Transduction Pathway by Interleukin-6-Type Cytokines Promotes , 2022 .

[54]  F. Buttgereit,et al.  Molecular mechanisms of glucocorticoid-induced osteoporosis. , 2001, Bone.

[55]  H. Cushing.  The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). 1932. , 1994, Obesity research.

[56]  Y. Oh,et al.  Overexpression of calbindin-D28K induces neurite outgrowth in dopaminergic neuronal cells via activation of p38 MAPK. , 2001, Biochemical and biophysical research communications.

[57]  G. Gronowicz,et al.  Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro. , 1999, Endocrinology.

[58]  C. Thompson,et al.  Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[59]  John Calvin Reed,et al.  The c‐IAP‐1 and c‐IAP‐2 proteins are direct inhibitors of specific caspases , 1997, The EMBO journal.

[60]  S. Christakos,et al.  Expression of Calbindin-D28k in a Pancreatic Isletβ -Cell Line Protects against Cytokine-Induced Apoptosis and Necrosis. , 2001, Endocrinology.